Archive for May, 2017|Monthly archive page

Quote of the Day

All government, in its essence, is organized exploitation, and in virtually all of its existing forms it is the implacable enemy of every industrious and well-disposed man.

— H. L. Mencken

Quote of the Day

No life ever grows great until it is focused, dedicated, disciplined. One of the widest gaps in human experience is the gap between what we say we want to be and our willingness to discipline ourselves to get there.

— Harry Emerson Fosdick

Quote of the Day

Many false opinions may be exchanged for true ones, without in the least altering the habits of mind of which false opinions are made.

… I am now convinced, that no great improvements in the lot of mankind are possible, until a great change takes place in the fundamental constitution of their modes of thought.

— John Stuart Mill

Quote of the Day

The conventional view serves to protect us from the painful job of thinking.

— John Kenneth Galbraith

Quote of the Day

Liberty is the possibility of doubting, the possibility of making a mistake, the possibility of searching and experimenting, the possibility of saying “No” to any authority — literary, artistic, philosophic, religious, social and even political.

— Ignazio Silone

Investment – Daily Recommendations

 

Symbol

Company

Sector

Horizon

Upside Target

Risk Profile

Rating

CYTX.US

Cytori Therapeutics

Biotechnology

Very-Short-Term

586.34%

 0.85

 1.17

ADXS.US

Advaxis

Biotechnology

Very-Short-Term

188.16%

 0.88

 1.17

RNN.US

Rexahn Pharmaceuticals

Biotechnology

Very-Short-Term

1571.34%

 0.74

 1.11

VTVT.US

Vtv Therapeutics

Pharmaceuticals

Very-Short-Term

219.97%

 0.79

 1.12

OCUL.US

Ocular Therapeutix

Pharmaceuticals

Very-Short-Term

245.42%

 0.70

 1.11

STML.US

Stemline Therapeutics

Biotechnology

Very-Short-Term

211.52%

 0.77

 1.42

GNCA.US

Genocea Biosciences

Biotechnology

Very-Short-Term

216.72%

 0.81

 1.56

CATB.US

Catabasis Pharmaceuticals

Biotechnology

Very-Short-Term

337.22%

 0.65

 1.85

AVXL.US

Anavex Life Sciences

Pharmaceuticals

Very-Short-Term

161.22%

 0.76

 1.08

PHARM.NL

Pharming Group

Biotechnology

Very-Short-Term

196.66%

 0.80

 1.00

PBMD.US

Prima Biomed

Biotechnology

Very-Short-Term

171.33%

 0.77

 1.12

ADMS.US

Adamas Pharmaceuticals

Pharmaceuticals

Short-Term

89.54%

 0.81

 1.23

RIGL.US

Rigel Pharmaceuticals

Pharmaceuticals

Very-Short-Term

123.89%

 0.71

 1.24

PLI.CA

Prometic Life Sciences

Biotechnology

Very-Short-Term

134.97%

 0.90

 1.37

ADAP.US

Adaptimmune Therapeutics

Biotechnology

Very-Short-Term

171.33%

 0.73

 1.77

AUPH.US

Aurinia Pharmaceuticals

Pharmaceuticals

Short-Term

53.10%

 0.84

 1.09

ABUS.US

Arbutus Biopharma

Biotechnology

Short-Term

119.32%

 0.80

 1.62

VBLT.US

Vascular Biogenics

Biotechnology

Very-Short-Term

65.36%

 0.72

 1.15